 |
|
Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome
Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim
Korean J Intern Med. 2012;27(1):47-52. Published online 2012 Feb 28 DOI: https://doi.org/10.3904/kjim.2012.27.1.47
|
|
Citations to this article as recorded by
 Comment on experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging
Sami Akbulut, Tevfik Tolga Sahin
International Journal of Surgery Case Reports.2020; 74: 36. CrossRef Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology
Ajay Duseja, Shivaram P. Singh, Vivek A. Saraswat, Subrat K. Acharya, Yogesh K. Chawla, Subhankar Chowdhury, Radha K. Dhiman, Rohinivilasam V. Jayakumar, Kaushal Madan, Sri P. Misra, Hrudananda Mishra, Sunil K. Modi, Arumugam Muruganathan, Banshi Saboo, R
Journal of Clinical and Experimental Hepatology.2015; 5(1): 51. CrossRef Body Mass Index and Waistline are Predictors of Survival for Hepatocellular Carcinoma After Hepatectomy
Jiangfeng Xu
Medical Science Monitor.2015; 21: 2203. CrossRef Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
Ajay Duseja, Naga Chalasani
Hepatology International.2013; 7(S2): 755. CrossRef Non-alcoholic Fatty Liver Disease: East Versus West
Swastik Agrawal, Ajay K Duseja
Journal of Clinical and Experimental Hepatology.2012; 2(2): 122. CrossRef
|